ALNY
Alnylam Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $59.82B | Price | $456.04 |
| Volume | 1.82M | Change | +1.44% |
| P/E Ratio | -215.1 | Open | $449.00 |
| Revenue | $2.2B | Prev Close | $449.56 |
| Net Income | $-278.2M | 52W Range | $205.87 - $495.55 |
| Div Yield | N/A | Target | $483.54 |
| Overall | 53 | Value | 40 |
| Quality | -- | Technical | 66 |
No chart data available
Stock Overview
Updated DailyAlnylam Pharmaceuticals Inc. (ALNY) is a leading Healthcare company in the Biotechnology industry, currently trading at $456.04 with a market capitalization of $59.82 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ALNY with a volume of 1.82 million shares. The stock opened down 0.12% from yesterday's close of $449.56. Current analyst estimates project earnings of $1.18 per share for this year, with next year targeting $6.71.
ALNY demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ARWR, REGN, SRPT, OPK, SNY.
Key investment considerations for ALNY include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 6.0%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 06:36 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $456.04 | +1.4% | 1.82M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW